|Articles|January 9, 2019
Elligo Health Research Acquires Protenium Clinical Research
Advertisement
Elligo Health Research, an integrated research organization, has acquired Protenium Clinical Research, an established research group led by Robert Strzinek, Ph.D., D.O. which conducts pharmaceutical studies in a broad range of therapeutic areas. The acquisition will bring the number of patients in Elligo’s Research Ready network to more than one million.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret
2
ACT Brief: Trial Execution Cost Burden and Protocol Variability, Real-World Oncology Data Curation Complexity, and Real-Time Analytics Datapoint Scale
3
ACT Brief: NIH Funding Reshaping Development Strategy, Business Decision Setting Execution Course, and Complex Modality Platform Gaps
4
You've Been Spending Recruitment Money at the Wrong End of the Funnel
5